Importance of monotherapy in women across the reproductive cycle

Neurology

Volumn 69, Issue 24 SUPPL. 3, 2007, Pages

  Montouris, Georgia ^a,b  

^a BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^b BOSTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CYTOCHROME P450 ISOENZYME; ETIRACETAM; FELBAMATE; GABAPENTIN; LAMOTRIGINE; ORAL CONTRACEPTIVE AGENT; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PREGABALIN; PRIMIDONE; TIAGABINE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN; VITAMIN K GROUP; ZONISAMIDE;

CLUBFOOT; CONGENITAL MALFORMATION; CRANIOFACIAL MALFORMATION; DRUG COST; DRUG SAFETY; DRUG USE; EPILEPSY; FEMALE; FEMALE FERTILITY; FETUS DEVELOPMENT; HEART ATRIUM SEPTUM DEFECT; HEART VENTRICLE SEPTUM DEFECT; HIP DISLOCATION; HUMAN; MONOTHERAPY; NEURAL TUBE DEFECT; OVARY CYCLE; PATENT DUCTUS ARTERIOSUS; PATIENT COMPLIANCE; POSTMENOPAUSE; PREGNANCY; PREGNANT WOMAN; PRIORITY JOURNAL; REVIEW; RISK REDUCTION; SEIZURE; TERATOGENICITY;

EID: 37349032182     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000302371.01359.c6     Document Type: Article

References (47)

1. Tettenborn B. Management of epilepsy in women of childbearing age: practical recommendations. CNS Drugs 2006;20:373-387.
2. Thomas SV. Management of epilepsy in pregnancy. J Postgrad Med 2006;52:57-64.
3. O'Brien MD, Gilmour-White SK. Management of epilepsy in women. Postgrad Med J 2005;81:278-285.
4. Yerby MS. Quality of life, epilepsy advances, and the evolving roles of anticonvulsants in women with epilepsy. Neurology 2000;55(suppl 1):S21-31.
5. Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter: management issues for women with epilepsy (summary statement). Neurology 1998;51:944-948.
6. Wallace H, Shorvon S, Tallis R. Age-specific incidence and prevalence rates of treated epilepsy in an unselected population of 2,052,922 and age-specific fertility rates of women with epilepsy. Lancet 1998;352:1970-1973.
7. Schupf N, Ottman R. Likelihood of pregnancy in individuals with idiopathic/cryptogenic epilepsy: social and biologic influences. Epilepsia 1994;35:750-756.
8. Webber MP, Hauser WA, Ottman R, Annegers JF. Fertility in persons with epilepsy: 1935-1974. Epilepsia 1986;27:746-752.
9. Morrell MJ. Guidelines for the care of women with epilepsy. Neurology 1998;51(suppl 4):S21-27.
10. Cummings LN, Guidice L, Morrell MJ. Ovulatory function in epilepsy. Epilepsia 1995;36:355-359.
11. Beastall GH, Cowan RA, Gray JM, Fogelman I. Hormone binding globulins and anticonvulsant therapy. Scot Med J 1985;30:101-105.
12. Liporace J, D'Abreau A. Epilepsy and women's health: family planning, bone health, menopause, and menstrual-related seizures. Mayo Clin Proc 2003;78:497-506.
13. Isojärvi JIT, Taubøll E, Herzog AG. Effect of antiepileptic drugs on reproductive endocrine function in individuals with epilepsy. CNS Drugs 2005;19:207-223.
14. Coulam CB, Annegers JF. Do anticonvulsants reduce the efficacy of oral contraceptives? Epilepsia 1979;20:519-525.
15. Zupanc ML. Antiepileptic drugs and hormonal contraceptives in adolescent women with epilepsy. Neurology 2006;66(suppl 3):S37-45.
16. Victor A, Lundberg PO, Johansson ED. Induction of sex hormone binding globulin by phenytoin. BMJ 1977;2:934-935.
17. Crawford P. Interactions between antiepileptic drugs and hormonal contraception. CNS Drugs 2002:16:263-272.
18. Sabers A, Buchholt JM, Uldall P, Hansen EL. Lamotrigine plasma levels reduced by oral contraceptives. Epilepsy Res 2001;47:151-154.
19. Pennell PB. Antiepileptic drug pharmacokinetics during pregnancy and lactation. Neurology 2003;61(suppl 2):S35-42.
20. EURAP Study Group. Seizure control and treatment in pregnancy: observations from the EURAP epilepsy pregnancy registry. Neurology 2006;66:354-360.
21. Lindhout D, Meinardi H, Meijer J, Nau H. Antiepileptic drugs and teratogenesis in two consecutive cohorts: changes in prescription policy paralleled by changes in pattern of malformations. Neurology 1992;42(suppl):94-110.
22. Adab N. Therapeutic monitoring of antiepileptic drugs during pregnancy and in the postpartum period. Is it useful? CNS Drugs 2006;20:791-800.
23. Committee on Educational Bulletins of the American College of Obstetricians and Gynecologists. ACOG educational bulletin. Seizure disorders in pregnancy. Number 231, December 1996. Int J Gynaecol Obstet 1997;56:279-286.
24. de Haan G-J, Edelbroek P, Segers J, et al. Gestation-induced changes in lamotrigine pharmacokinetics: a monotherapy study. Neurology 2004;63:571-573.
25. Tran TA, Leppik IE, Blesi K, Sathanandan ST, Remmel R. Lamotrigine clearance during pregnancy. Neurology 2002;59:251-255.
26. Perucca E. Birth defects after prenatal exposure to antiepileptic drugs. Lancet Neurol 2005;4:781-786.
27. Modzelesky A. Pregnancy registry reps announce current data, need for more births to be reported. http://www.epilepsyfoundation.org/epilepsyusa/ between/pregregistry042005.cfm. Accessed May 21, 2007.
28. Breen DP, Davenport RJ. Teratogenicity of antiepileptic drugs. Women should consider stopping, minimising, or switching drugs before pregnancy. BMJ 2006;333:615-616.
29. Samrén EB, van Duijn CM, Koch S, et al. Maternal use of antiepileptic drugs and risk of major congenital malformations: a joint European prospective study of human teratogenesis associated with maternal epilepsy. Epilepsia 1997;38:981-990.
30. Wyszynski DF, Nambisan M, Surve T, et al., for the Antiepileptic Dug Pregnancy Registry. Increased rate of major malformations in offspring exposed to valproate during pregnancy. Neurology 2005;64:961-965.
31. Vajda FJ, Hitchcock A, Graham J, et al. Foetal malformations and seizure control: 52 months data of the Australian Pregnancy Registry. Eur J Neurol 2006;13:645-654.
32. Wide K, Winbladh B, Källén B. Major malformations in infants exposed to antiepileptic drugs in utero, with emphasis on carbamazepine and valproic acid: a nation-wide, population-based register study. Acta Paediatr 2004;93:174-176.
33. Holmes LB, Wyszynski DF, Lieberman E. The AED (antiepileptic drug) Pregnancy Registry. A 6-year experience. Arch Neurol 2004;61:673-678.
34. Samrén EB, van Duijn CM, Christiaens GCML, Hoffman A, Lindhout D. Antiepileptic drug regimens and major congenital abnormalities in the offspring. Ann Neurol 1999;46:739-746.
35. Dravet C, Julian C, Legras C, et al. Epilepsy, antiepileptic drugs, and malformations in children of women with epilepsy: a French prospective cohort study. Neurology 1992;42(suppl 5):75-82.
36. Nakane Y, Okuma T, Takahashi R, et al. Multiinstitutional study on the teratogenicity and fetal toxicity of antiepileptic drugs: a report of a collaborative study group in Japan. Epilepsia 1980;21:663-680.
37. Holmes LB, Wyszynski DF, Lieberman E. The AED (antiepileptic drug) Pregnancy Registry. A 6-year experience. Arch Neurol 2004;61:673-678.
38. Pennell PB. Using current evidence in selecting antiepileptic drugs for use during pregnancy. Epilepsy Currents 2005;5:45-51.
39. Cunnington M, Tennis P, and the International Lamotrigine Pregnancy Registry Scientific Advisory Committee. Lamotrigine and the risk of malformations in pregnancy. Neurology 2005;64:955-960.
40. Morrow J, Russell A, Guthrie E, et al. Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry 2006;77:193-198.
41. Montouris G. Safety of the newer antiepileptic drug oxcarbazepine during pregnancy. Curr Med Res Opin 2005;21:693-701.
42. Yerby MS. Management issues for women with epilepsy. Neural tube defects and folic acid supplementation. Neurology 2003;61(suppl 2):S23-26.
43. Klein P, Van Passel-Clark LM, Pezzullo JC. Onset of epilepsy at the time of menarche. Neurology 2003;60:495-497.
44. Herzog AG. Menstrual disorders in women with epilepsy. Neurology 2006;66(suppl 3):S23-28.
45. Harden CL. Menopause and bone density issues for women with epilepsy. Neurology 2003;61(suppl 2):S16-22.
46. Harden CL, Herzog AG, Nikolov BG, et al. Hormone replacement therapy in women with epilepsy: a randomized, double-blind, placebo-controlled study. Epilepsia 2006;47:1447-1451.
47. Pack AM, Morrell MJ. Treatment of women with epilepsy. Semin Neurol 2002;22:289-292.